
Objective To evaluate patient satisfaction levels in a gynecological teaching clinic and to explore its associated influencing factors, so as to provide evidence for optimizing the operational model of teaching clinics. Methods This was a single-center retrospective cross-sectional survey. Patients who attended the gynecological teaching clinic(teaching clinic group) and the general outpatient clinic(general clinic group) at Peking Union Medical College Hospital from May 2023 to July 2025 were enrolled. Satisfaction wasassessed using the Chinese version of the Patient Satisfaction Questionnaire-18, with the 5-level ordinal overall satisfaction as the primary outcome. Ordinal logistic regression was employed to identify independent influencing factors of satisfaction. Results A total of 1146 patients(578 in the teaching clinic group and 568 in the general clinic group) were enrolled, among whom 985 completed the questionnaire follow-up(496 in the teaching clinic group and 489 in the general clinic group), yielding a response rate of 85.95%. The 5-level ordinal overall satisfaction was higher in the teaching clinic group than in the general clinic group(OR=6.09, 95% CI: 3.74-9.91, P u0026lt; 0.001), and the overall satisfaction score was also significantly higher in the teaching clinic group[(3.99u00B10.26) vs.(3.92u00B10.46), 95% CI: 0.02-0.11, P=0.005]. In terms of subdomains, the teaching clinic group scored better in doctor-patient communication[(3.99u00B10.57) vs.(3.81u00B10.63), P u0026lt; 0.001], but scored lower in technical service quality[(3.03u00B10.19) vs.(3.26u00B10.48), P u0026lt; 0.001] and humanistic care[(3.32u00B10.53) vs.(3.46u00B10.62), P u0026lt; 0.001] compared with the general clinic group. Multivariable ordinal logistic regression analysis showed that consultation duration u2265 10 minutes(OR=1.75, 95% CI: 1.14-2.70, P=0.011) and the teaching clinic model(OR=5.39, 95% CI: 3.25-8.95, P u0026lt; 0.001) were independent positive influencing factors for higher patient satisfaction. Conclusions Patient satisfaction in the gynecological teaching clinic is relatively high, with notable strength in doctor-patient communication; however, there remains room for improvement in technical service quality and humanistic care. Adequate consultation duration and the teaching clinic model are associated with higher patient satisfaction.
Objective To investigate the epidemiological characteristics of venous thromboembolism (VTE) among inpatients at the People's Hospital of Xizang Autonomous Region, and to provide data support for the establishment of a standardized risk screening and pharmaceutical care system in the plateau chronic disease pharmaceutical clinic. Methods This study was a retrospective cross-sectional survey. Patients discharged with a diagnosis of VTE from the People's Hospital of Xizang Autonomous Region between January 2019 and December 2024 were selected. General data, clinical outcomes, and anticoagulation regimens were collected. The Mann-Kendall trend test was used to analyze the temporal trend of VTE prevalence, and multivariate Logistic regression was used to analyze the influencing factors of VTE occurrence. Results A total of 939 VTE patients were included, comprising 492 females (52.40%) and 447 males (47.60%), with a mean age of (54.87u00B120.10) years. There were 339 elderly patients aged u226565 years and 600 patients aged u0026lt; 65 years. In terms of treatment outcomes, the clinical improvement (improvement) rate was 79.02%, and the cure rate was 10.76%. Among thrombus types, pulmonary embolism (PE) accounted for the highest proportion (58.79%), with low-risk PE being the main subtype (35.50%). The main comorbidity among VTE patients was hypertension (39.94%), followed by acute myocardial infarction or ischemic stroke (11.40%). The prevalence of VTE increased from 0.62% in 2019 to 1.07% in 2024. The Mann-Kendall trend test showed a Kendall's Tau coefficient of 0.733 (P=0.028), indicating a significant upward trend in the proportion of VTE patients at the hospital from 2019 to 2024. Univariate Logistic regression analysis showed that age u226565 years, hypertension, overweight/obesity, diabetes, tumor, history of cardiovascular events, elevated D-dimer, decreased estimated glomerular filtration rate (eGFR), high hemoglobin, and inpatient department were significantly associated with the occurrence of VTE (all P u0026lt; 0.05). Multivariate Logistic regression analysis showed that after adjusting for sex, ethnicity, inpatient department, D-dimer, eGFR, tumor, diabetes, history of cardiovascular events, history of VTE, and recent surgical history, hypertension (aOR=2.30, 95% CI: 1.80-2.94, P u0026lt; 0.001), overweight/obesity (aOR=1.78, 95% CI: 1.34-2.36, P u0026lt; 0.001), and age u226565 years (aOR=1.28, 95% CI: 1.01-1.62, P=0.041) were significantly positively correlated with VTE, while high hemoglobin was significantly negatively correlated with VTE (aOR=0.75, 95% CI: 0.59-0.95, P=0.018). Subgroup analysis showed that among internal medicine patients, hypertension (aOR=2.51, 95% CI: 1.89-3.33, P u0026lt; 0.001) and overweight/obesity (aOR=1.92, 95% CI: 1.40-2.63, P u0026lt; 0.001) were significantly positively correlated with VTE; while among surgical patients, only hypertension was significantly positively correlated with VTE (aOR=1.92, 95% CI: 1.20-3.07, P=0.007). Age stratification results showed that among patients aged u0026lt; 65 years, overweight/obesity was significantly positively correlated with VTE (aOR=2.05, 95% CI: 1.48-2.84, P u0026lt; 0.001); while among patients aged u226565 years, overweight/obesity was not significantly associated with VTE (aOR=1.41, 95% CI: 0.94-2.12, P=0.098). Discharge anticoagulation was mainly rivaroxaban monotherapy (43.56%), and 33.33% of patients were discharged without anticoagulant medication. Conclusions The prevalence of VTE at the People's Hospital of Xizang Autonomous Region is on the rise. The key risk population consists of chronic disease patients with hypertension and obesity. It is necessary to further strengthen early identification of VTE, management of comorbidities, and medication monitoring for chronic disease patients, so as to improve the comprehensive management of VTE in plateau areas.
Objective To investigate the clinical application value of indocyanine green(ICG) fluorescence-guided thoracoscopic lung lesion resection under the diagnosis related group(DRG) payment system, and to provide reference for the management of new medical technologies in healthcare institutions. Methods Discharged patients who underwent thoracoscopic segmentectomy and/or wedge resection at Peking Union Medical College Hospital from January 1, 2016 to May 31, 2024 were enrolled. Patients who received ICG fluorescence guidance were assigned to new technology group, while those who did not receive ICG fluorescence guidance were assigned to control group. Operative time, length of stay, cost consumption index, time consumption index, duration of ventilator use, total hospitalization cost, and 10 representative cost items were compared between the two groups. Propensity score matching(PSM) was further used to analyze the changes in these indicators after controlling for confounding factors including age, sex, DRG code, and surgical type. Results A total of 7999 patients who met the inclusion and exclusion criteria were enrolled, including 1392 patients(17.4%) in the new technology group and 6607 patients(82.6%) in the control group. Compared with the control group, the new technology group showed significantly shorter operative time and length of stay, and significant reductions in time consumption index, consultation and diagnostic fees, nursing fees, therapeutic medical material fees, bed fees, oxygen therapy fees, antibiotic fees, and albumin product fees, while the cost consumption index, total hospitalization cost, surgical fees, and surgical medical material fees were significantly increased(all P u0026lt; 0.001). Among EB15(major thoracic surgery without important complications or comorbidities) patients, all indicators except duration of ventilator use, western medicine fees, and duration of invasive mechanical ventilation showed statistically significant differences between the two groups(all P u0026lt; 0.001). Among patients in EB11(major thoracic surgery with important complications or comorbidities), only albumin product fees were significantly lower in the new technology group than those in the control group(P=0.003), with no statistically significant differences in other indicators(P u0026gt; 0.05). In patients undergoing wedge resection alone, the new technology group showed significantly shorter operative time and length of hospital stay, as well as significant reductions in time consumption index, consultation and diagnostic fees, nursing fees, therapeutic medical material fees, bed fees, oxygen therapy fees, western medicine fees, antibiotic fees, and albumin product fees, total hospitalization cost and cost consumption index, while surgical medical material fees increased (P u0026lt; 0.05). After PSM, the operative time in the new technology group was significantly shorter than that in the control group(P=0.022); except for increased western medicine fees, oxygen therapy fees, antibiotic fees, albumin product fees, and therapeutic medical material fees in the new technology group were all significantly lower than those in the control group(all P u0026lt; 0.05). Conclusions ICG fluorescence-guided thoracoscopic lung lesion resection can significantly improve medical efficiency, optimize cost structure, and reduce perioperative supportive resource consumption. However, its clinical benefits vary significantly among patients with different surgical types or different DRG groups, so clinicians are advised to strengthen preoperative precise evaluation.
Patients with gouty arthritis may encounter a range of perioperative challenges in orthopedic settings, including acute gout flares and infectious complications, which not only compromise patient well-being but may also adversely affect surgical outcomes and escalate healthcare costs. To date, there is a paucity of guidelines or consensus statements specifically addressing the perioperative management of gouty arthritis, both domestically and internationally, resulting in a lack of standardized clinical protocols. Consequently, there is an urgent need to develop evidence-based expert consensus to optimize diagnostic and therapeutic strategies. In response, the Department of Orthopedics at Peking Union Medical College Hospital convened a multidisciplinary panel of experts to formulate the Chinese Expert Consensus on Perioperative Management of Gouty Arthritis (2025), drawing upon the latest advances in the relevant literature. This consensus yields 10 recom-mendations addressing the potential perioperative issues and corresponding prophylactic and therapeutic approaches for patients with gouty arthritis. The recommendations encompass four key domains: preoperative evaluation and risk stratification, intraoperative technical optimization, perioperative pharmacological management, and postoperative complication management. The consensus is intended to provide guidance for the perioperative care of gouty arthritis patients, with the ultimate goals of improving surgical outcomes, reducing the risk of perioperative complications, and enhancing patient prognosis.
In the field of critical care medicine, coagulopathy is no longer viewed as an isolated hemostatic abnormality or thrombotic event, but rather as a core effector of the host/organ unregulated response (HOUR) to severe injury. Conventional monitoring modalities based primarily on plasma coagulation tests exhibit considerable lag and fail to capture the dynamic evolution of hypercoagulability and endothelial injury in the early phase of critical illness. This article systematically proposes the "Critical Care Coagulation ResponseAssessment and Monitoring System" and establishes a novel conceptual framework that "hypercoagulability is the norm, while hypocoagulability is the consequence." We advocate for viscoelastic testing as the cornerstone, deeply integrated with the four thrombus-related molecular biomarkers, and combined with conventional coagulation parameters and platelet function analysis, to constitute a multidimensional phenotypic assessment protocol for coagulation responses.Furthermore, we elaborate on how dynamic monitoring of coagulation responses enables the construction of a temporal profile of coagulopathic evolution, allowing early identification of key pathological processes including endothelial glycocalyx shedding, thrombin burst, and fibrinolysis shutdown, thereby distinguishing physiological coagulation responses from pathological coagulopathy/disease and even disseminated intravascular coagulation. On this basis, we propose phenotype-guided precision anticoagulation, component blood product transfusion, and endothelial protective strategies, aiming to provide clinicians with a complete closed-loop management framework from mechanistic elucidation to bedside decision-making. Importantly, we position coagulation response management as a critical node in HOUR stewardship-not only pivotal for thrombotic and hemorrhagic risk control, but also a key intervention pathway to prevent disease progression, reduce the incidence of multiple organ dysfunction syndrome, and ultimately improve outcomes in critically ill patients.